Top compounds associated with response to RNMT


Feature Type Standardized
Nominal ANOVA
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.043 0.2
mRNA ML311 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA manumycin A CTRPv2 pan-cancer AAC 0.043 0.2
mRNA MK-0752 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.2
mRNA Crizotinib CCLE pan-cancer AAC -0.059 0.2
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.2
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.043 0.2
mRNA shikonin GDSC1000 pan-cancer AAC -0.044 0.2
Download CSV